US Patent 11786518 Ophthalmic formulations and uses thereof
Patent 11786518 was granted and assigned to Aldeyra Therapeutics on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+43 properties)
Article (+177 characters)
US Patent 11786518 Ophthalmic formulations and uses thereof
Article
Patent abstract
The present invention provides a reproxalap ophthalmic solution, and methods of using the same for treating a disease or disorder such as allergic conjunctivitis.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
David Clark
Lise Lund Kjems
Stephen Gitu Machatha
Susan Macdonald
Date of Patent
October 17, 2023
Patent Application Number
16825898
Date Filed
March 20, 2020
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11786518 Ophthalmic formulations and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
